Organization · Venture Capital
Transpose Platform
Transpose Platform is a global early-stage venture capital firm based in Houston, Texas, focusing on investing in frontier founders and innovative companies across various sectors, including AI, biotech, and healthcare.
Overview
What Transpose Platform does
What Transpose Platform is
Transpose Platform is a global early-stage venture capital firm based in Houston, Texas, focusing on investing in frontier founders and innovative companies across various sectors, including AI, biotech, and healthcare.
How it participates in the startup ecosystem
The current public profile supports funder and community and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder · Community · Event host
- Last reviewed
- April 24, 2026
Official channels
Find Transpose Platform elsewhere
Open the official website or a supported primary organization account.
Capability profile
Transpose Platform as a funder
Investment thesis
Transpose Platform is a formation stage venture capital fund that invests from Day 0 as a first-check investor, focusing on innovative companies across various sectors. The fund operates a hybrid model, making direct investments and backing emerging VC funds.
Focus narrative
Transpose Platform invests in a variety of sectors including AI, biotech, climate tech, consumer products, fintech, healthcare, and more. The organization targets early-stage investments and aims to cultivate category-defining companies across diverse geographies, leveraging its extensive network and expertise to support portfolio companies.
Value beyond capital
Transpose Platform adds value to its portfolio companies through strategic guidance, access to a robust network of industry contacts, and support in navigating the complexities of early-stage growth. The fund also facilitates co-investment opportunities and provides resources for scaling operations and market entry.
Terms and economics
- Typical check
- $4,000,000–$5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B
- Sectors
- Artificial IntelligenceBiotech & Life SciencesClimate & SustainabilityConsumerFintechHealthcareMarketing & Advertising Tech
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 513
Portfolio context
Transpose Platform's portfolio includes notable companies across multiple sectors: AI / ML: Agentic Labs, Allus AI Inc; Biotech: A51, Allozymes; Enterprise Software: APMI, Adamo Technologies, Additor; Fintech: Acko, April Tax, Aquila; Healthcare: AccuRx, Anqalab, Anonymous Health; Marketing: AdsGency AI, Aimerce; Manufacturing: Alljoined, Allude, Ambinet Inc.
Capability profile
Transpose Platform as a community
Community overview
Transpose Platform is a global formation stage venture capital fund founded to support early-stage companies and the funds that accelerate them. The organization is based in the United States and focuses on partnering with founders to build innovative companies.
Community focus
Transpose Platform invests in a variety of sectors including AI, biotech, climate tech, consumer products, fintech, healthcare, and more. The organization targets early-stage investments and aims to cultivate category-defining companies across diverse geographies.
Membership
- Pricing models
- free
Format and cadence
- Modality
- in-person
- Schedule
- rolling-admissions
- Commitment
- light
Availability
- Membership state
- Accepting
Audience and fit
- Audience
- Founders · Investors
- Benefits
- network-access
- Program types
- community
- Selection criteria
- open
- Stages
- Pre-seed · Seed · Seed+
- Sectors
- Artificial IntelligenceBiotech & Life SciencesClimate & SustainabilityConsumerFintechHealthcare
- Regions
- Global · North America
Community activity
Events and activity
Transpose Platform hosts 'Ecosystem Days' events for its portfolio and limited partner community, providing networking and collaboration opportunities.
Notable members
Alex Bangash, Managing Director and General Partner; Fiyin Olayisade, Partner; James Tan, Partner and Director of Early Stage Investments; Nikos Liodakis, Partner.
Capability profile
Transpose Platform as an event host
Event focus
Transpose Platform is a global formation stage venture capital fund that focuses on partnering with founders to build innovative companies. The organization invests in a variety of sectors including AI, biotech, climate tech, consumer products, fintech, and healthcare, targeting early-stage investments to cultivate category-defining companies across diverse geographies.
Participant value
Transpose Platform aims to provide first-check investments to early-stage companies and supports them through a strong co-investor network, leveraging its portfolio of 83+ unicorns to foster growth and innovation.
Format and cadence
- Startups can present
- No
Availability
- Registration state
- Accepting
Audience and fit
- Stages
- Pre-seed · Seed
- Audience
- Founders · Investors · Fund Managers
- Regions
- United States · Global
Common questions
What to know about Transpose Platform
Upseed classifies Transpose Platform under the Venture Capital organization type. Its current public profile includes funder, community, and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.